Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Claritas Genomics | RCV000449634 | SCV000537827 | likely pathogenic | Peripheral neuropathy | 2016-08-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000762330 | SCV000892636 | pathogenic | not provided | 2018-08-01 | criteria provided, single submitter | clinical testing | |
Clinical Genetics and Genomics, |
RCV000762330 | SCV001449542 | likely pathogenic | not provided | 2019-12-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000762330 | SCV003837510 | pathogenic | not provided | 2023-02-08 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16826520, 31230720, 30868735, 34426522, 26752647) |
Duke University Health System Sequencing Clinic, |
RCV001007785 | SCV003918956 | likely pathogenic | Autosomal recessive multiple pterygium syndrome | 2023-04-20 | criteria provided, single submitter | research | |
Center of Genomic medicine, |
RCV001007785 | SCV004098980 | likely pathogenic | Autosomal recessive multiple pterygium syndrome | 2023-01-17 | criteria provided, single submitter | clinical testing | The patient harbours this variant in an homozygous state, each copy being inherited form each parent |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003479120 | SCV004223810 | pathogenic | Lethal multiple pterygium syndrome | 2023-11-14 | criteria provided, single submitter | clinical testing | Variant summary: CHRNG c.256C>T (p.Arg86Cys) results in a non-conservative amino acid change located in the neurotransmitter-gated ion-channel transmembrane domain (IPR006029) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.6e-05 in 248786 control chromosomes (gnomAD). c.256C>T has been reported in the literature as a biallelic genotype in multiple individuals affected with Escobar Syndrome/Lethal Multiple Pterygium Syndrome - CHRNG Related (e.g. Hoffmann_2006, Bayram_2016, Pehlivan_2019). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 16826520, 26752647, 31230720). Six submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Center for Genomic Medicine, |
RCV001007785 | SCV004807824 | pathogenic | Autosomal recessive multiple pterygium syndrome | 2024-03-29 | criteria provided, single submitter | clinical testing | |
Lupski Lab, |
RCV001007785 | SCV001167470 | likely pathogenic | Autosomal recessive multiple pterygium syndrome | no assertion criteria provided | research |